ホーム › 頭頸部扁平上皮癌 › コネチカット州 › New Haven
New Haven、CTにおける頭頸部扁平上皮癌の臨床試験
New Havenとその周辺地域（約30マイル以内）の拠点で、頭頸部扁平上皮癌に関する22件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
被験者募集中第1相
- Exelixis Clinical Site #62, New Haven
A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
被験者募集中第1相
- Smilow Cancer Hospital - Yale New Haven Health, New Haven
- Yale - New Haven Hospital - Yale Cancer Center, New Haven
- Smilow Cancer Hospital Phase 1 Unit, New Haven
Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors
被験者募集中第1相
- Yale University - Yale University School of Medicine, New Haven
A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer
被験者募集中第3相
- Yale Cancer Center, New Haven
A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Head and Neck Cancer
被験者募集中第1/2相
- Yale Cancer Center, New Haven
Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma
被験者募集中第2相
- Smilow Cancer Center/Yale-New Haven Hospital, New Haven
- Yale University, New Haven
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
被験者募集中第1相
- Yale University, Yale Cancer Center, New Haven
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
被験者募集中第2相
- Smilow Cancer Center/Yale-New Haven Hospital, New Haven
- Yale University, New Haven
- Yale-New Haven Hospital North Haven Medical Center, North Haven · 7マイル先
- 他1件
First in Human Study of TUB-030 in Patients With Advanced Solid Tumors
被験者募集中第1/2相
- Yale Cancer Center, New Haven
ADCE-T02, a Tissue Factor Targeted Antibody-Drug Conjugate, in Patients With Selected Advanced Solid Tumours
被験者募集中第1相
- Yale University Cancer Center, New Haven
A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
被験者募集中第1相
- Normunity Investigational Site, New Haven
Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer
被験者募集中第2/3相
- Yale University, New Haven
CUE-101with Pembrolizumab for Locally Advanced HPV+HNSCCs
被験者募集中第2相健康なボランティア歓迎
- Yale University, New Haven
A Study to Investigate ALE.P02 as Monotherapy in Adult Patients With Selected CLDN1+ Solid Tumors
被験者募集中第1/2相
- Yale Comprehensive Cancer Center, New Haven
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
被験者募集中第1/2相
- Yale University, Yale Cancer Center, New Haven
5-Azacytidine and/or Nivolumab in Resectable HPV-Associated HNSCC
被験者募集中第2相
- Yale University, New Haven
Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors
被験者募集中第1相
- Yale University School of Medicine /ID# 225707, New Haven
A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma
被験者募集中第3相
- GSK Investigational Site, New Haven
A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma
被験者募集中第3相
- Yale School of Medicine - Smilow Cancer Hospital, New Haven
A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer
被験者募集中第1/2相
- Yale Cancer Center, New Haven
Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067
被験者募集中第1/2相
- Yale Cancer Center, New Haven
Phase II Trial of Neoadjuvant and Adjuvant IO102-IO103 and Pembrolizumab KEYTRUDA® in Patients With Resectable Tumors
被験者募集中第2相
- Yale, New Haven
他の都市における頭頸部扁平上皮癌の試験
- Houston, TX47件の研究
- Los Angeles, CA42件の研究
- Boston, MA40件の研究
- New York City, NY39件の研究
- Nashville, TN39件の研究
- St. Louis, MO28件の研究
- Arlington, VA26件の研究
- Philadelphia, PA26件の研究
- Chicago, IL26件の研究
- Atlanta, GA24件の研究
- San Antonio, TX22件の研究
- Pittsburgh, PA22件の研究
New Havenにおける他の研究
- 非小細胞肺癌41件の研究
- 乳がん38件の研究
- がん（全種類）33件の研究
- 転移性癌23件の研究
- 肺がん22件の研究
- 卵巣がん21件の研究
- 大腸癌20件の研究
- 前立腺がん20件の研究
- 急性骨髄性白血病17件の研究
- アルコール使用障害（AUD）17件の研究
- オピオイド過剰摂取17件の研究
- 膵臓がん16件の研究
ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。